Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors.
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors. Clin Cancer Res. 2020 12 01; 26(23):6196-6203.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Antineoplastic Agents
Antineoplastic Agents
Case-Control Studies
Case-Control Studies
Female
Female
Follow-Up Studies
Follow-Up Studies
Glucocorticoid-Induced TNFR-Related Protein
Glucocorticoid-Induced TNFR-Related Protein
Humans
Humans
Immunoglobulin G
Immunoglobulin G
Male
Male
Middle Aged
Middle Aged
Neoplasms
Neoplasms
Prognosis
Prognosis
Retrospective Studies
Retrospective Studies
authors with profiles
Raid Aljumaily